What is Augmedix Inc share price today?

Augmedix Inc (AUGX) share price today is {{live_price}}.

Can Indians buy Augmedix Inc shares?

Yes, Indians can invest in the Augmedix Inc (AUGX) from India. With INDmoney, you can buy Augmedix Inc at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Augmedix Inc at zero transaction cost.

How can I buy Augmedix Inc shares from India?

It is very easy to buy Augmedix Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Augmedix Inc be purchased?

Yes, you can buy fractional shares of Augmedix Inc with INDmoney app.

What are the documents required to start investing in Augmedix Inc stocks?

To start investing in Augmedix Inc, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Augmedix Inc

Today’s highest price of Augmedix Inc (AUGX) is {{1_rba_end}}. Today’s lowest price of Augmedix Inc (AUGX) is {{1_rba_st}}.

What is today's market capitalisation of Augmedix Inc

Today's market capitalisation of Augmedix Inc AUGX is 114.2M

What is the 52 Week High and Low Range of Augmedix Inc

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Augmedix Inc is down from its 52 Week High?

Augmedix Inc (AUGX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Augmedix Inc is up from its 52 Week low?

Augmedix Inc (AUGX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Augmedix Inc?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Augmedix Inc

Mr. Emmanuel Krakaris is the current Chief Executive Officer (CEO) of Augmedix Inc.

Home>
US Stocks>
Augmedix Inc

Augmedix Inc (AUGX)

$2.31

Market is closed - opens 7 PM, 09 Sep 2024

Performance

$2.31
$2.32
$2.31
0.0%
Downside
Day's Volatility :0.43%
Upside
0.43%
$0.73
$6.25
$2.31
68.4%
Downside
52 Weeks Volatility :88.32%
Upside
63.04%

Returns

Period	Augmedix Inc	Index (Russel 2000)
3 Months	171.0%	0.0%
6 Months	-40.0%	0.0%
1 Year	-51.06%	0.0%
3 Years	-34.0%	-22.3%

Highlights

Market Capitalization	114.2M
Book Value	$0.21
Earnings Per Share (EPS)	-0.47
Wall Street Target Price	3.52

Profit Margin	-46.23%
Operating Margin TTM	-63.85%

Return On Assets TTM	-30.61%
Return On Equity TTM	-329.78%

Revenue TTM	51.6M
Revenue Per Share TTM	1.03
Quarterly Revenue Growth YOY	26.8%
Gross Profit TTM	14.0M
EBITDA	-22.5M
Diluted Eps TTM	-0.47
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	-0.53
EPS Estimate Next Year	-0.47
EPS Estimate Current Quarter	-0.13
EPS Estimate Next Quarter	-0.14

Analyst Recommendation

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Augmedix Inc(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 52.38%

Current $2.31

Target $3.52

Company Financials

	FY19	Y/Y Change
Revenue	14.1M	-
Net Income	-22.4M	-
Net Profit Margin	-158.5%	-

	FY20	Y/Y Change
Revenue	16.5M	↑ 16.84%
Net Income	-14.7M	↓ 34.1%
Net Profit Margin	-89.41%	↑ 69.09%

	FY21	Y/Y Change
Revenue	22.2M	↑ 34.47%
Net Income	-17.2M	↑ 16.44%
Net Profit Margin	-77.42%	↑ 11.99%

	FY22	Y/Y Change
Revenue	30.9M	↑ 39.56%
Net Income	-26.5M	↑ 54.59%
Net Profit Margin	-85.76%	↓ 8.34%

	FY23	Y/Y Change
Revenue	44.9M	↑ 45.01%
Net Income	-19.2M	↓ 27.73%
Net Profit Margin	-42.74%	↑ 43.02%

	Q1 FY23	Q/Q Change
Revenue	8.8M	↑ 0.0%
Net Income	-5.8M	↑ 2.84%
Net Profit Margin	-65.8%	↓ 1.82%

	Q2 FY23	Q/Q Change
Revenue	10.8M	↑ 23.19%
Net Income	-5.0M	↓ 12.59%
Net Profit Margin	-46.69%	↑ 19.11%

	Q3 FY23	Q/Q Change
Revenue	11.8M	↑ 9.16%
Net Income	-4.4M	↓ 12.44%
Net Profit Margin	-37.45%	↑ 9.24%

	Q4 FY23	Q/Q Change
Revenue	12.7M	↑ 7.76%
Net Income	-4.5M	↑ 1.91%
Net Profit Margin	-35.42%	↑ 2.03%

	Q1 FY24	Q/Q Change
Revenue	13.5M	↑ 6.24%
Net Income	-6.5M	↑ 44.71%
Net Profit Margin	-48.24%	↓ 12.82%

	Q2 FY24	Q/Q Change
Revenue	13.7M	↑ 1.43%
Net Income	-8.5M	↑ 30.02%
Net Profit Margin	-61.84%	↓ 13.6%

	FY19	Y/Y Change
Total Assets	15.7M	-
Total Liabilities	80.9M	-

	FY20	Y/Y Change
Total Assets	27.9M	↑ 77.49%
Total Liabilities	24.8M	↓ 69.32%

	FY21	Y/Y Change
Total Assets	51.7M	↑ 85.01%
Total Liabilities	28.0M	↑ 12.85%

	FY22	Y/Y Change
Total Assets	33.6M	↓ 34.91%
Total Liabilities	32.2M	↑ 14.91%

	FY23	Y/Y Change
Total Assets	66.7M	↑ 98.31%
Total Liabilities	43.4M	↑ 34.86%

	Q1 FY23	Q/Q Change
Total Assets	33.6M	↑ 0.0%
Total Liabilities	32.2M	↑ 0.0%

	Q2 FY23	Q/Q Change
Total Assets	43.8M	↑ 30.34%
Total Liabilities	39.9M	↑ 23.88%

	Q3 FY23	Q/Q Change
Total Assets	40.8M	↓ 6.88%
Total Liabilities	40.1M	↑ 0.6%

	Q4 FY23	Q/Q Change
Total Assets	66.7M	↑ 63.38%
Total Liabilities	43.4M	↑ 8.21%

	Q1 FY24	Q/Q Change
Total Assets	59.6M	↓ 10.73%
Total Liabilities	41.8M	↓ 3.72%

	Q2 FY24	Q/Q Change
Total Assets	53.7M	↓ 9.88%
Total Liabilities	43.2M	↑ 3.4%

	FY18	Y/Y Change
Operating Cash Flow	-19.9M	-
Investing Cash Flow	-341.6K	-
Financing Cash Flow	22.1M	-

	FY19	Y/Y Change
Operating Cash Flow	-14.6M	↓ 26.39%
Investing Cash Flow	-823.0K	↑ 140.95%
Financing Cash Flow	17.2M	↓ 22.49%

	FY20	Y/Y Change
Operating Cash Flow	-14.4M	↓ 1.68%
Investing Cash Flow	-647.0K	↓ 21.38%
Financing Cash Flow	26.4M	↑ 53.87%

	FY21	Y/Y Change
Operating Cash Flow	-18.6M	↑ 29.12%
Investing Cash Flow	-611.0K	↓ 5.57%
Financing Cash Flow	37.8M	↑ 43.19%

	FY22	Y/Y Change
Operating Cash Flow	-16.8M	↓ 9.78%
Investing Cash Flow	-1.4M	↑ 130.44%
Financing Cash Flow	-1.2M	↓ 103.27%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-4.4M	↑ 0.0%
Investing Cash Flow	-173.0K	↓ 70.78%
Financing Cash Flow	7.0K	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	-6.0M	↑ 35.75%
Investing Cash Flow	-1.3M	↑ 652.6%
Financing Cash Flow	11.9M	↑ 169671.43%

Technicals Summary

Sell

Neutral

Buy

Augmedix Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Augmedix Inc	2.67%	-40.0%	-51.06%	-34.0%	-34.0%
Solventum Corp	18.43%	-4.2%	-4.2%	-4.2%	-4.2%
Doximity, Inc.	42.51%	26.66%	54.18%	-63.01%	-31.43%
Veeva Systems Inc.	18.46%	-6.2%	-2.75%	-30.3%	49.39%
Ge Healthcare Technologies Inc.	7.25%	-8.17%	29.12%	40.67%	40.67%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Augmedix Inc	NA	NA	NA	-0.53	-3.3	-0.31	NA	0.21
Solventum Corp	NA	NA	NA	6.26	0.17	0.08	NA	NA
Doximity, Inc.	45.43	45.43	2.42	0.9	0.17	0.11	NA	4.92
Veeva Systems Inc.	57.42	57.42	1.39	4.76	0.13	0.06	NA	32.04
Ge Healthcare Technologies Inc.	25.23	25.23	2.26	4.24	0.21	0.06	0.0	17.08

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Augmedix Inc	Buy	$114.2M	-34.0%	NA	-46.23%
Solventum Corp	Hold	$10.8B	-4.2%	NA	15.73%
Doximity, Inc.	Hold	$6.7B	-31.43%	45.43	32.53%
Veeva Systems Inc.	Buy	$35.0B	49.39%	57.42	23.91%
Ge Healthcare Technologies Inc.	Buy	$39.9B	40.67%	25.23	8.1%

Insights on Augmedix Inc

Increasing Revenue
Revenue is up for the last 17 quarters, 3.72M → 13.66M (in $), with an average increase of 7.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -4.40M → -8.45M (in $), with an average decrease of 25.6% per quarter
Vs DOCS
In the last 1 year, Doximity, Inc. has given 54.2% return, outperforming this stock by 105.3%